VCG
Vantage Consulting Group’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,005
| Closed | -$233K | – | 24 |
|
|
2024
Q2 | $233K | Sell |
1,005
-60
| -6% | -$13.9K | 0.17% | 135 |
|
|
2024
Q1 | $230K | Buy |
1,065
+86
| +9% | +$18.5K | 0.15% | 156 |
|
|
2023
Q4 | $253K | Buy |
979
+80
| +9% | +$20.7K | 0.17% | 106 |
|
|
2023
Q3 | $231K | Buy |
899
+157
| +21% | +$40.4K | 0.15% | 142 |
|
|
2023
Q2 | $211K | Sell |
742
-193
| -21% | -$55K | 0.12% | 190 |
|
|
2023
Q1 | $260K | Buy |
935
+89
| +11% | +$24.7K | 0.15% | 133 |
|
|
2022
Q4 | $234K | Sell |
846
-362
| -30% | -$100K | 0.14% | 151 |
|
|
2022
Q3 | $323K | Sell |
1,208
-10
| -0.8% | -$2.67K | 0.19% | 64 |
|
|
2022
Q2 | $248K | Buy |
1,218
+58
| +5% | +$11.8K | 0.14% | 129 |
|
|
2022
Q1 | $244K | Buy |
1,160
+42
| +4% | +$8.83K | 0.1% | 155 |
|
|
2021
Q4 | $268K | Buy |
1,118
+305
| +38% | +$73.1K | 0.07% | 159 |
|
|
2021
Q3 | $230K | Buy |
813
+235
| +41% | +$66.5K | 0.05% | 160 |
|
|
2021
Q2 | $200K | Buy |
+578
| New | +$200K | 0.03% | 200 |
|
|
2021
Q1 | – | Sell |
-303
| Closed | -$74K | – | 285 |
|
|
2020
Q4 | $74K | Buy |
+303
| New | +$74K | 0.01% | 281 |
|